Digestive Diseases and Sciences

, Volume 58, Issue 3, pp 634–640 | Cite as

High Expression of Gastrin Receptor Protein in Injured Mucosa of Helicobacter pylori-Positive Gastritis

  • Akemi Takamura
  • Masanori ItoEmail author
  • Tomoyuki Boda
  • Yoko Matsumoto
  • Shinji Tanaka
  • Masaharu Yoshihara
  • Kazuaki Chayama
Original Article


Background and Aim

Gastrin is a growth factor for the gastric epithelial cells. However, it is unknown how gastric receptor (GR) expression is regulated in the gastric mucosa. We studied GR expression using a newly raised antibody and investigated the relationship between GR expression and gastritis.


Gastric receptor expression in 63 human gastric mucosa was studied. Helicobacter pylori infection and histological gastritis status were evaluated in gastric biopsy samples. In gastric ulcer cases, additional biopsy specimens were taken from injured mucosa. Fasting sera were collected and serum gastrin level evaluated. MKN-28 cells were cultured at various pH conditions, and the change in GR expression was determined.


Gastric receptor expression was detected in the foveolar epithelium of the gastric mucosa, and its expression was stronger in patients infected with H. pylori. In particular, higher expression was detected in regenerating injured mucosa. There was no association between gastritis score/serum gastrin level and GR expression in H. pylori-positive cases. In MKN-28 cells, GR protein expression was lower in neutral conditions than in acidic or alkaline conditions.


Gastric mucosal injury with H. pylori infection destroys the pH barrier on the foveolar epithelium and may induce GR expression through pH changes.


Gastrin Gastrin receptor Gastritis Helicobacter pylori Gastric acid 



Gastrin receptor


Proton pump inhibitor

H. pylori

Helicobacter pylori


Conflict of interest



  1. 1.
    Tahara E. Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol. 1990;116:121–131.PubMedCrossRefGoogle Scholar
  2. 2.
    Ochiai A, Yasui W, Tahara E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res. 1985;76:1064–1071.PubMedGoogle Scholar
  3. 3.
    Naito Y, Ito M, Watanabe T, Suzuki H. Biomarkers in patients with gastric inflammation: a systematic review. Digestion. 2005;72:164–180.PubMedCrossRefGoogle Scholar
  4. 4.
    Ito M, Haruma K, Kaya S, et al. Serological comparison of serum pepsinogen and anti-parietal cell antibody levels between Japanese and German patients. Eur J Gastroenterol Hepatol. 2002;14:123–127.PubMedCrossRefGoogle Scholar
  5. 5.
    Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin-active participant or bystander in gastric carcinogenesis? Nat Rev Cancer. 2006;12:936–946.CrossRefGoogle Scholar
  6. 6.
    Ose T, Kadowaki Y, Fukuhara H, et al. Reg I-knockout mice reveal its role in regulation of cell growth that is required in generation and maintenance of the villous structure of small intestine. Oncogene. 2007;26:349–359.PubMedCrossRefGoogle Scholar
  7. 7.
    Chiba T, Fukui H, Kinoshita Y. Reg protein: a possible mediator of gastrin-induced mucosal cell growth. J Gastroenterol. 2000;35:52–56.PubMedCrossRefGoogle Scholar
  8. 8.
    Sumiyoshi H, Yasui W, Ochiai A, Tahara E. Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice. Cancer Res. 1984;44:4276–4280.PubMedGoogle Scholar
  9. 9.
    McWilliams DF, Watson SA, Crosbee DM, Michaeli D, Seth R. Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines. Gut. 1998;42:795–798.PubMedCrossRefGoogle Scholar
  10. 10.
    Lee YM, Beinborn M, McBride EW, Lu M, Kolakowski LF Jr, Kopin AS. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem. 1993;268:8164–8169.PubMedGoogle Scholar
  11. 11.
    Kazumori H, Ishihara S, Kawashima K, Fukuda R, Chiba T, Kinoshita Y. Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection. FEBS Lett. 2001;489:208–214.PubMedCrossRefGoogle Scholar
  12. 12.
    Schmitz F, Göke MN, Otte JM, et al. Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa. Regul Pept. 2001;102:101–110.PubMedCrossRefGoogle Scholar
  13. 13.
    Kulaksiz H, Arnold R, Goke B, et al. Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach. Cell Tissue Res. 2000;299:289–298.PubMedCrossRefGoogle Scholar
  14. 14.
    Henwood M, Clarke PA, Smith AM, Watson SA. Expression of gastrin in developing gastric adenocarcinoma. Br J Surg. 2001;88:564–568.PubMedCrossRefGoogle Scholar
  15. 15.
    Kumamoto T, Sumii K, Haruma K, Tari A, Tanaka K, Kajiyama G. Gastrin receptors in the human gastrointestinal tract and pancreas. Gastroenterol Jpn. 1989;24:109–114.PubMedGoogle Scholar
  16. 16.
    Ito M, Tanaka S, Maeda M, et al. Role of the gastrin–gastrin receptor system in the expansive growth of human gastric neoplasms. Digestion. 2008;78:163–170.PubMedCrossRefGoogle Scholar
  17. 17.
    Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1–15.PubMedCrossRefGoogle Scholar
  18. 18.
    Ito M, Takata S, Tatsugami M, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol. 2009;44:365–371.PubMedCrossRefGoogle Scholar
  19. 19.
    Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston. Am J Surg Pathol. 1996;20:1161–1181.PubMedCrossRefGoogle Scholar
  20. 20.
    Ito M, Tanaka S, Kim S, et al. A combination of the Helicobacter pylori stool antigen test and urea breath test is useful for clinical evaluation of eradication therapy: a multicenter study. J Gastroenterol Hepatol. 2005;20:1241–1245.PubMedCrossRefGoogle Scholar
  21. 21.
    Yoshihara M, Sumii K, Haruma K, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol. 1998;93:1090–1096.PubMedCrossRefGoogle Scholar
  22. 22.
    Kulaksiz H, Arnold R, Goke B, et al. Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach. Cell Tissue Res. 2000;299:289–298.PubMedCrossRefGoogle Scholar
  23. 23.
    Fukuhara H, Kadowaki Y, Ose T, et al. In vivo evidence for the role of RegI in gastric regeneration: transgenic overexpression of RegI accelerates the healing of experimental gastric ulcers. Lab Invest. 2010;90:556–565.PubMedCrossRefGoogle Scholar
  24. 24.
    Ashurst HL, Varro A, Dimaline R. Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo. Exp Physiol. 2008;93:223–236.PubMedCrossRefGoogle Scholar
  25. 25.
    Haruma K, Yoshihara M, Sumii K, et al. Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma. Scand J Gastroenterol. 1993;28:633–637.PubMedCrossRefGoogle Scholar
  26. 26.
    Hongo M, Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol. 2010;45:618–624.PubMedCrossRefGoogle Scholar
  27. 27.
    Phillipson M, Atuma C, Henriksnäs J, Holm L. The importance of mucus layers and bicarbonate transport in preservation of gastric juxtamucosal pH. Am J Physiol Gastrointest Liver Physiol. 2002;282:G211–G219.PubMedGoogle Scholar
  28. 28.
    Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 2000;118:36–47.PubMedCrossRefGoogle Scholar
  29. 29.
    Takaishi S, Cui G, Frederick DM, et al. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology. 2005;128:1965–1983.PubMedCrossRefGoogle Scholar
  30. 30.
    Fukui T, Nishio A, Okazaki K, et al. Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice. Gut. 2006;55:607–615.PubMedCrossRefGoogle Scholar
  31. 31.
    Kawasaki D, Emori Y, Eta R, et al. Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro. Cancer Chemother Pharmacol. 2008;61:883–892.PubMedCrossRefGoogle Scholar
  32. 32.
    Savage K, Waller HA, Stubbs M, et al. Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines. Int J Oncol. 2006;29:1429–1435.PubMedGoogle Scholar
  33. 33.
    Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010;45:1–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Akemi Takamura
    • 1
  • Masanori Ito
    • 1
    Email author
  • Tomoyuki Boda
    • 1
  • Yoko Matsumoto
    • 1
  • Shinji Tanaka
    • 2
  • Masaharu Yoshihara
    • 3
  • Kazuaki Chayama
    • 1
  1. 1.Department of Gastroenterology and MetabolismHiroshima UniversityMinami-ku, HiroshimaJapan
  2. 2.Department of EndoscopyHiroshima University HospitalHiroshimaJapan
  3. 3.Health Service CenterHiroshima UniversityHigashi-HiroshimaJapan

Personalised recommendations